SPDR S&P Pharmaceuticals ETF
XPH
XPH
55 hedge funds and large institutions have $166M invested in SPDR S&P Pharmaceuticals ETF in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5M | |
| 2 | +$4.08M | |
| 3 | +$3.66M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.64M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.02M |
Top Sellers
| 1 | -$42M | |
| 2 | -$20.2M | |
| 3 | -$7.79M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.55M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.98M |